nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertindole—CYP2D6—breast cancer	0.192	0.538	CbGaD
Sertindole—CYP3A4—breast cancer	0.165	0.462	CbGaD
Sertindole—HTR6—Raloxifene—breast cancer	0.121	0.263	CbGbCtD
Sertindole—CYP3A4—Exemestane—breast cancer	0.0351	0.076	CbGbCtD
Sertindole—CYP2D6—Idarubicin—breast cancer	0.0317	0.0686	CbGbCtD
Sertindole—CYP3A4—Letrozole—breast cancer	0.0298	0.0646	CbGbCtD
Sertindole—CYP3A4—Anastrozole—breast cancer	0.0266	0.0576	CbGbCtD
Sertindole—CYP3A4—Toremifene—breast cancer	0.0243	0.0526	CbGbCtD
Sertindole—CYP3A4—Fulvestrant—breast cancer	0.0226	0.0489	CbGbCtD
Sertindole—CYP3A4—Thiotepa—breast cancer	0.0202	0.0436	CbGbCtD
Sertindole—CYP3A4—Ixabepilone—breast cancer	0.0184	0.0399	CbGbCtD
Sertindole—CYP3A4—Lapatinib—breast cancer	0.0178	0.0384	CbGbCtD
Sertindole—CYP2D6—Vinorelbine—breast cancer	0.0155	0.0335	CbGbCtD
Sertindole—CYP2D6—Tamoxifen—breast cancer	0.014	0.0302	CbGbCtD
Sertindole—CYP3A4—Raloxifene—breast cancer	0.0135	0.0291	CbGbCtD
Sertindole—CYP3A4—Vinorelbine—breast cancer	0.00985	0.0213	CbGbCtD
Sertindole—CYP2D6—Vinblastine—breast cancer	0.00954	0.0206	CbGbCtD
Sertindole—CYP3A4—Tamoxifen—breast cancer	0.00889	0.0192	CbGbCtD
Sertindole—CYP3A4—Mitoxantrone—breast cancer	0.00867	0.0188	CbGbCtD
Sertindole—CYP3A4—Paclitaxel—breast cancer	0.00692	0.015	CbGbCtD
Sertindole—CYP3A4—Irinotecan—breast cancer	0.00683	0.0148	CbGbCtD
Sertindole—CYP3A4—Vinblastine—breast cancer	0.00607	0.0131	CbGbCtD
Sertindole—CYP2D6—Doxorubicin—breast cancer	0.00586	0.0127	CbGbCtD
Sertindole—CYP3A4—Docetaxel—breast cancer	0.005	0.0108	CbGbCtD
Sertindole—CYP3A4—Doxorubicin—breast cancer	0.00373	0.00807	CbGbCtD
Sertindole—HTR1E—female gonad—breast cancer	0.000608	0.0453	CbGeAlD
Sertindole—ADRA1D—epithelium—breast cancer	0.000551	0.0411	CbGeAlD
Sertindole—KCNH2—nipple—breast cancer	0.000454	0.0339	CbGeAlD
Sertindole—Haloperidol—CYP1A1—breast cancer	0.000445	0.133	CrCbGaD
Sertindole—Domperidone—CYP2D6—breast cancer	0.000435	0.13	CrCbGaD
Sertindole—ADRA1D—female reproductive system—breast cancer	0.000409	0.0305	CbGeAlD
Sertindole—Domperidone—CYP3A4—breast cancer	0.000373	0.111	CrCbGaD
Sertindole—HRH1—nipple—breast cancer	0.000364	0.0271	CbGeAlD
Sertindole—Pimozide—CYP2D6—breast cancer	0.000363	0.108	CrCbGaD
Sertindole—ADRA2A—nipple—breast cancer	0.000357	0.0267	CbGeAlD
Sertindole—ADRA1D—endocrine gland—breast cancer	0.000346	0.0258	CbGeAlD
Sertindole—Haloperidol—CYP2D6—breast cancer	0.000331	0.0989	CrCbGaD
Sertindole—ADRA1A—epithelium—breast cancer	0.000316	0.0236	CbGeAlD
Sertindole—HTR1B—female reproductive system—breast cancer	0.000316	0.0236	CbGeAlD
Sertindole—Pimozide—CYP3A4—breast cancer	0.000311	0.093	CrCbGaD
Sertindole—Domperidone—ABCB1—breast cancer	0.00031	0.0927	CrCbGaD
Sertindole—HTR1D—female reproductive system—breast cancer	0.000306	0.0228	CbGeAlD
Sertindole—HTR2C—female reproductive system—breast cancer	0.000303	0.0226	CbGeAlD
Sertindole—SLC6A4—female reproductive system—breast cancer	0.000287	0.0214	CbGeAlD
Sertindole—Haloperidol—CYP3A4—breast cancer	0.000284	0.0849	CrCbGaD
Sertindole—KCNH2—endometrium—breast cancer	0.000274	0.0204	CbGeAlD
Sertindole—HTR1B—endocrine gland—breast cancer	0.000267	0.0199	CbGeAlD
Sertindole—Pimozide—ABCB1—breast cancer	0.000259	0.0774	CrCbGaD
Sertindole—ADRA1A—adipose tissue—breast cancer	0.000256	0.0191	CbGeAlD
Sertindole—KCNH2—uterus—breast cancer	0.000252	0.0188	CbGeAlD
Sertindole—DRD2—pituitary gland—breast cancer	0.000252	0.0188	CbGeAlD
Sertindole—HTR2A—embryo—breast cancer	0.000251	0.0187	CbGeAlD
Sertindole—HTR1A—adrenal gland—breast cancer	0.000249	0.0186	CbGeAlD
Sertindole—KCNH2—pituitary gland—breast cancer	0.000248	0.0185	CbGeAlD
Sertindole—HRH1—epithelium—breast cancer	0.000245	0.0183	CbGeAlD
Sertindole—SLC6A4—endocrine gland—breast cancer	0.000243	0.0181	CbGeAlD
Sertindole—Haloperidol—ABCB1—breast cancer	0.000237	0.0707	CrCbGaD
Sertindole—ADRA1A—adrenal gland—breast cancer	0.000229	0.0171	CbGeAlD
Sertindole—KCNH2—female reproductive system—breast cancer	0.000227	0.0169	CbGeAlD
Sertindole—KCNH2—adrenal gland—breast cancer	0.000222	0.0165	CbGeAlD
Sertindole—HRH1—endometrium—breast cancer	0.00022	0.0164	CbGeAlD
Sertindole—HTR1A—endocrine gland—breast cancer	0.000216	0.0161	CbGeAlD
Sertindole—ADRA2A—endometrium—breast cancer	0.000216	0.0161	CbGeAlD
Sertindole—KCNH2—bone marrow—breast cancer	0.000214	0.016	CbGeAlD
Sertindole—KCNH2—female gonad—breast cancer	0.000207	0.0154	CbGeAlD
Sertindole—HTR2A—epithelium—breast cancer	0.000205	0.0153	CbGeAlD
Sertindole—ADRA1A—endocrine gland—breast cancer	0.000199	0.0148	CbGeAlD
Sertindole—ADRA2A—uterus—breast cancer	0.000199	0.0148	CbGeAlD
Sertindole—HRH1—adipose tissue—breast cancer	0.000198	0.0148	CbGeAlD
Sertindole—ADRA2A—pituitary gland—breast cancer	0.000195	0.0146	CbGeAlD
Sertindole—DRD2—endocrine gland—breast cancer	0.000195	0.0145	CbGeAlD
Sertindole—ADRA2A—adipose tissue—breast cancer	0.000194	0.0145	CbGeAlD
Sertindole—KCNH2—endocrine gland—breast cancer	0.000192	0.0143	CbGeAlD
Sertindole—HRH1—female reproductive system—breast cancer	0.000182	0.0136	CbGeAlD
Sertindole—ADRA2A—female reproductive system—breast cancer	0.000179	0.0133	CbGeAlD
Sertindole—HRH1—adrenal gland—breast cancer	0.000178	0.0132	CbGeAlD
Sertindole—ADRA2A—adrenal gland—breast cancer	0.000174	0.013	CbGeAlD
Sertindole—HTR2A—pituitary gland—breast cancer	0.000166	0.0124	CbGeAlD
Sertindole—HRH1—female gonad—breast cancer	0.000166	0.0123	CbGeAlD
Sertindole—ADRA2A—female gonad—breast cancer	0.000163	0.0121	CbGeAlD
Sertindole—HRH1—endocrine gland—breast cancer	0.000154	0.0115	CbGeAlD
Sertindole—HTR2A—female reproductive system—breast cancer	0.000152	0.0113	CbGeAlD
Sertindole—ADRA2A—endocrine gland—breast cancer	0.000151	0.0113	CbGeAlD
Sertindole—HTR2A—adrenal gland—breast cancer	0.000148	0.0111	CbGeAlD
Sertindole—CYP3A4—female reproductive system—breast cancer	0.000141	0.0105	CbGeAlD
Sertindole—CYP2D6—female reproductive system—breast cancer	0.000138	0.0103	CbGeAlD
Sertindole—KCNH2—lymph node—breast cancer	0.000133	0.00991	CbGeAlD
Sertindole—HTR2A—endocrine gland—breast cancer	0.000129	0.00959	CbGeAlD
Sertindole—CYP2D6—female gonad—breast cancer	0.000126	0.0094	CbGeAlD
Sertindole—CYP3A4—endocrine gland—breast cancer	0.000119	0.00888	CbGeAlD
Sertindole—CYP2D6—endocrine gland—breast cancer	0.000117	0.00874	CbGeAlD
Sertindole—HRH1—lymph node—breast cancer	0.000106	0.00794	CbGeAlD
Sertindole—ADRA2A—lymph node—breast cancer	0.000105	0.0078	CbGeAlD
Sertindole—DRD3—Signaling Pathways—TGFB1—breast cancer	3.11e-06	1.89e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—PIK3CA—breast cancer	3.09e-06	1.88e-05	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—AKT1—breast cancer	3.08e-06	1.87e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CXCL8—breast cancer	3.07e-06	1.87e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—PTEN—breast cancer	3.07e-06	1.87e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	3.06e-06	1.87e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CDKN1B—breast cancer	3.06e-06	1.87e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CDKN1B—breast cancer	3.06e-06	1.86e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MDM2—breast cancer	3.05e-06	1.86e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—HRAS—breast cancer	3.05e-06	1.86e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CASP3—breast cancer	3.05e-06	1.86e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IL2—breast cancer	3.05e-06	1.85e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—EGFR—breast cancer	3.05e-06	1.85e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—EGFR—breast cancer	3.05e-06	1.85e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MAPK8—breast cancer	3.04e-06	1.85e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—RAF1—breast cancer	3.04e-06	1.85e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—AKT1—breast cancer	3.03e-06	1.85e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—IL6—breast cancer	3.03e-06	1.85e-05	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—AKT1—breast cancer	3.03e-06	1.84e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—RELA—breast cancer	3.03e-06	1.84e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—SRC—breast cancer	3.03e-06	1.84e-05	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—AKT1—breast cancer	3.02e-06	1.84e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—PIK3CA—breast cancer	3.02e-06	1.84e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CG—breast cancer	3.02e-06	1.84e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—SRC—breast cancer	3.01e-06	1.83e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—TP53—breast cancer	3.01e-06	1.83e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—ERBB2—breast cancer	3.01e-06	1.83e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CASP3—breast cancer	3e-06	1.83e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	3e-06	1.83e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IL2—breast cancer	3e-06	1.83e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CASP3—breast cancer	3e-06	1.82e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IL2—breast cancer	2.99e-06	1.82e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—TP53—breast cancer	2.99e-06	1.82e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—IL6—breast cancer	2.98e-06	1.82e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—IL6—breast cancer	2.98e-06	1.81e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—PIK3CA—breast cancer	2.98e-06	1.81e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CCND1—breast cancer	2.97e-06	1.81e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MTOR—breast cancer	2.97e-06	1.81e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	2.97e-06	1.81e-05	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	2.97e-06	1.81e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—JUN—breast cancer	2.96e-06	1.8e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—VEGFA—breast cancer	2.95e-06	1.8e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CTNNB1—breast cancer	2.94e-06	1.79e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CASP3—breast cancer	2.94e-06	1.79e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IL2—breast cancer	2.94e-06	1.79e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—VEGFA—breast cancer	2.93e-06	1.79e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—TP53—breast cancer	2.93e-06	1.78e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CCND1—breast cancer	2.92e-06	1.78e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—IL6—breast cancer	2.92e-06	1.78e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—STAT3—breast cancer	2.92e-06	1.78e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—JUN—breast cancer	2.92e-06	1.78e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CCND1—breast cancer	2.92e-06	1.78e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—JUN—breast cancer	2.91e-06	1.77e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—COMT—breast cancer	2.91e-06	1.77e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—STAT3—breast cancer	2.9e-06	1.77e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2.89e-06	1.76e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GSTP1—breast cancer	2.89e-06	1.76e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CTNNB1—breast cancer	2.89e-06	1.76e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—SRC—breast cancer	2.88e-06	1.76e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MMP9—breast cancer	2.88e-06	1.76e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—HRAS—breast cancer	2.88e-06	1.75e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—TP53—breast cancer	2.88e-06	1.75e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—KRAS—breast cancer	2.88e-06	1.75e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—KRAS—breast cancer	2.88e-06	1.75e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CDKN1A—breast cancer	2.87e-06	1.75e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PTEN—breast cancer	2.87e-06	1.75e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CCND1—breast cancer	2.86e-06	1.74e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—HRAS—breast cancer	2.86e-06	1.74e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—JUN—breast cancer	2.86e-06	1.74e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—HMOX1—breast cancer	2.85e-06	1.74e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CXCL8—breast cancer	2.85e-06	1.74e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—ITPR1—breast cancer	2.85e-06	1.73e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MMP9—breast cancer	2.84e-06	1.73e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—HRAS—breast cancer	2.84e-06	1.73e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	2.83e-06	1.73e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MMP9—breast cancer	2.83e-06	1.72e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CDKN1A—breast cancer	2.83e-06	1.72e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.82e-06	1.72e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PTEN—breast cancer	2.82e-06	1.72e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PTEN—breast cancer	2.81e-06	1.71e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—VEGFA—breast cancer	2.81e-06	1.71e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MAPK8—breast cancer	2.8e-06	1.71e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—HRAS—breast cancer	2.8e-06	1.7e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—AKT1—breast cancer	2.8e-06	1.7e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MAPK3—breast cancer	2.79e-06	1.7e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	2.79e-06	1.7e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—STAT3—breast cancer	2.78e-06	1.69e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MMP9—breast cancer	2.78e-06	1.69e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MAPK3—breast cancer	2.78e-06	1.69e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	2.77e-06	1.69e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PTEN—breast cancer	2.76e-06	1.68e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MAPK8—breast cancer	2.76e-06	1.68e-05	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	2.76e-06	1.68e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—IL6—breast cancer	2.76e-06	1.68e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MAPK8—breast cancer	2.75e-06	1.68e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—HRAS—breast cancer	2.75e-06	1.68e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—AKT1—breast cancer	2.75e-06	1.68e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—AKT1—breast cancer	2.75e-06	1.67e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—ABCB1—breast cancer	2.74e-06	1.67e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—IL6—breast cancer	2.73e-06	1.66e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CASP3—breast cancer	2.73e-06	1.66e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IL2—breast cancer	2.73e-06	1.66e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—IL6—breast cancer	2.71e-06	1.65e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MYC—breast cancer	2.71e-06	1.65e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—TGFB1—breast cancer	2.71e-06	1.65e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MAPK8—breast cancer	2.7e-06	1.64e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MYC—breast cancer	2.7e-06	1.64e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—AKT1—breast cancer	2.69e-06	1.64e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—TGFB1—breast cancer	2.69e-06	1.64e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—TYMS—breast cancer	2.69e-06	1.64e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—IL6—breast cancer	2.68e-06	1.63e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GSTM1—breast cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—NCOR1—breast cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CCND1—breast cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—SRC—breast cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MAPK3—breast cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CD—breast cancer	2.66e-06	1.62e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—EGFR—breast cancer	2.65e-06	1.62e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—JUN—breast cancer	2.65e-06	1.62e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	2.64e-06	1.61e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—PIK3CA—breast cancer	2.64e-06	1.61e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—EGFR—breast cancer	2.64e-06	1.61e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—IL6—breast cancer	2.63e-06	1.6e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	2.63e-06	1.6e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—ALB—breast cancer	2.62e-06	1.6e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—SRC—breast cancer	2.62e-06	1.59e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—SRC—breast cancer	2.61e-06	1.59e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—VEGFA—breast cancer	2.59e-06	1.58e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MYC—breast cancer	2.58e-06	1.57e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MMP9—breast cancer	2.58e-06	1.57e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—TGFB1—breast cancer	2.58e-06	1.57e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	2.57e-06	1.57e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PTEN—breast cancer	2.57e-06	1.56e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—STAT3—breast cancer	2.56e-06	1.56e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—SRC—breast cancer	2.56e-06	1.56e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—TP53—breast cancer	2.56e-06	1.56e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—TP53—breast cancer	2.56e-06	1.56e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—VEGFA—breast cancer	2.55e-06	1.55e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GPX1—breast cancer	2.55e-06	1.55e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—VEGFA—breast cancer	2.54e-06	1.55e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—AKT1—breast cancer	2.54e-06	1.55e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—EGFR—breast cancer	2.53e-06	1.54e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—AKT1—breast cancer	2.52e-06	1.54e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—STAT3—breast cancer	2.52e-06	1.54e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CYP1A1—breast cancer	2.52e-06	1.53e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—STAT3—breast cancer	2.52e-06	1.53e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MAPK8—breast cancer	2.51e-06	1.53e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—NOS3—breast cancer	2.51e-06	1.53e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—KRAS—breast cancer	2.51e-06	1.53e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—AKT1—breast cancer	2.5e-06	1.52e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—ERCC2—breast cancer	2.5e-06	1.52e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—VEGFA—breast cancer	2.49e-06	1.52e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—KRAS—breast cancer	2.49e-06	1.52e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—AKT1—breast cancer	2.47e-06	1.5e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—STAT3—breast cancer	2.47e-06	1.5e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MAPK3—breast cancer	2.45e-06	1.49e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—HRAS—breast cancer	2.45e-06	1.49e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—HRAS—breast cancer	2.45e-06	1.49e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—AKT1—breast cancer	2.43e-06	1.48e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MAPK3—breast cancer	2.41e-06	1.47e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MAPK3—breast cancer	2.4e-06	1.46e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—KRAS—breast cancer	2.39e-06	1.45e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MYC—breast cancer	2.38e-06	1.45e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—SRC—breast cancer	2.38e-06	1.45e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—TGFB1—breast cancer	2.38e-06	1.45e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MAPK3—breast cancer	2.36e-06	1.44e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—MTHFR—breast cancer	2.35e-06	1.43e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MYC—breast cancer	2.34e-06	1.43e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IL6—breast cancer	2.34e-06	1.42e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IL6—breast cancer	2.34e-06	1.42e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MYC—breast cancer	2.34e-06	1.42e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—TGFB1—breast cancer	2.34e-06	1.42e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—TGFB1—breast cancer	2.33e-06	1.42e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—EGFR—breast cancer	2.33e-06	1.42e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—VEGFA—breast cancer	2.32e-06	1.41e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CB—breast cancer	2.31e-06	1.41e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—PIK3CA—breast cancer	2.3e-06	1.4e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MYC—breast cancer	2.3e-06	1.4e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—STAT3—breast cancer	2.3e-06	1.4e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PTGS2—breast cancer	2.29e-06	1.4e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—EGFR—breast cancer	2.29e-06	1.4e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—PIK3CA—breast cancer	2.29e-06	1.4e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—TGFB1—breast cancer	2.29e-06	1.39e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—EGFR—breast cancer	2.29e-06	1.39e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—EGFR—breast cancer	2.24e-06	1.37e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—TP53—breast cancer	2.23e-06	1.36e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—TP53—breast cancer	2.22e-06	1.35e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—KRAS—breast cancer	2.2e-06	1.34e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	2.19e-06	1.34e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MAPK3—breast cancer	2.19e-06	1.33e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CAV1—breast cancer	2.17e-06	1.32e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—KRAS—breast cancer	2.17e-06	1.32e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—PIK3CA—breast cancer	2.17e-06	1.32e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—KRAS—breast cancer	2.16e-06	1.32e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—AKT1—breast cancer	2.16e-06	1.31e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—AKT1—breast cancer	2.16e-06	1.31e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MYC—breast cancer	2.13e-06	1.3e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—HRAS—breast cancer	2.13e-06	1.3e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—TGFB1—breast cancer	2.13e-06	1.3e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—TP53—breast cancer	2.12e-06	1.29e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—KRAS—breast cancer	2.12e-06	1.29e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—HRAS—breast cancer	2.12e-06	1.29e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—EGFR—breast cancer	2.09e-06	1.27e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IL6—breast cancer	2.04e-06	1.24e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—HRAS—breast cancer	2.03e-06	1.24e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IL6—breast cancer	2.03e-06	1.24e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PIK3CA—breast cancer	2.02e-06	1.23e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PTEN—breast cancer	2e-06	1.22e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.99e-06	1.21e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.99e-06	1.21e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CG—breast cancer	1.97e-06	1.2e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.97e-06	1.2e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—TP53—breast cancer	1.96e-06	1.19e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.95e-06	1.19e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IL6—breast cancer	1.94e-06	1.18e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—TP53—breast cancer	1.93e-06	1.17e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—TP53—breast cancer	1.92e-06	1.17e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—TP53—breast cancer	1.88e-06	1.15e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—AKT1—breast cancer	1.88e-06	1.15e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—AKT1—breast cancer	1.87e-06	1.14e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—HRAS—breast cancer	1.87e-06	1.14e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—HRAS—breast cancer	1.84e-06	1.12e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—HRAS—breast cancer	1.84e-06	1.12e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.81e-06	1.1e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.8e-06	1.1e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.79e-06	1.09e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IL6—breast cancer	1.79e-06	1.09e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—AKT1—breast cancer	1.77e-06	1.08e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IL6—breast cancer	1.76e-06	1.07e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IL6—breast cancer	1.76e-06	1.07e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—TP53—breast cancer	1.75e-06	1.07e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CD—breast cancer	1.74e-06	1.06e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IL6—breast cancer	1.73e-06	1.05e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—ALB—breast cancer	1.71e-06	1.04e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.67e-06	1.02e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—AKT1—breast cancer	1.65e-06	1.01e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—NOS3—breast cancer	1.64e-06	9.98e-06	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—AKT1—breast cancer	1.63e-06	9.9e-06	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—AKT1—breast cancer	1.62e-06	9.88e-06	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IL6—breast cancer	1.6e-06	9.76e-06	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.59e-06	9.69e-06	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CB—breast cancer	1.51e-06	9.21e-06	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PTGS2—breast cancer	1.5e-06	9.13e-06	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.48e-06	9e-06	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CA—breast cancer	1.41e-06	8.59e-06	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PTEN—breast cancer	1.31e-06	7.96e-06	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—AKT1—breast cancer	1.15e-06	7.02e-06	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CA—breast cancer	9.22e-07	5.62e-06	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—AKT1—breast cancer	7.54e-07	4.59e-06	CbGpPWpGaD
